Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 181, Issue 2, Pages 376-379Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2012.06.006
Keywords
-
Categories
Funding
- NEI NIH HHS [K12 EY016335, K12-EY16335, R01 EY005318, EY05318, R01 EY015435, EY015435] Funding Source: Medline
Ask authors/readers for more resources
In 1994, The American Journal of Pathology published a key article reporting that hypoxic retina produces vascular endothelial growth factor (VEGF), suggesting a role for VEGF in ocular neovascularization. Subsequent developments in anti-VEGF treatment for neovascular eye disease have improved visual outcomes and changed the standard of care in retinal medicine and ophthalmology. (Am J Pathol 2012, 181: 376-379; http://dx.doi.org/10.1016/j.ajpath.2012.06.006)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
